Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma

被引：4
|
作者：
Killock, David
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2019年 / 16卷 / 05期
关键词：
D O I：
10.1038/s41571-019-0192-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
    Herrlinger, Ulrich
    Rieger, Johannes
    Koch, Dorothee
    Loeser, Simon
    Blaschke, Britta
    Kortmann, Rolf-Dieter
    Steinbach, Joachim P.
    Hundsberger, Thomas
    Wick, Wolfgang
    Meyermann, Richard
    Tan, Ta-Chih
    Sommer, Clemens
    Bamberg, Michael
    Reifenberger, Guido
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417
  • [22] Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial
    Tremont-Lukats, Ivo W.
    Teh, Bin S.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S589 - S591
  • [23] <bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS
    Lazaridis, Lazaros
    Schaefer, Niklas
    Schmidt, Teresa
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    NEURO-ONCOLOGY, 2019, 21 : 229 - 230
  • [24] Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma
    Skardelly, Marco
    Dangel, Elena
    Gohde, Julia
    Noell, Susan
    Behling, Felix
    Lepski, Guilherme
    Borchers, Christian
    Koch, Marilin
    Schittenhelm, Jens
    Bisdas, Sotirios
    Naumann, Aline
    Paulsen, Frank
    Zips, Daniel
    von Hehn, Ulrike
    Ritz, Rainer
    Tatagiba, Marcos Soares
    Tabatabai, Ghazaleh
    ONCOLOGIST, 2017, 22 (05): : 570 - 575
  • [25] Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
    Takeuchi, Satoru
    Wada, Kojiro
    Nagatani, Kimihiro
    Otani, Naoki
    Osada, Hideo
    Nawashiro, Hiroshi
    NEUROLOGY INDIA, 2014, 62 (01) : 42 - 47
  • [26] The role of temozolomide in newly-diagnosed glioblastoma multiforme
    Jenkinson, Michael D.
    BRITISH JOURNAL OF NEUROSURGERY, 2008, 22 (03) : 456 - 456
  • [27] Temozolomide approved in Europe for newly diagnosed glioblastoma multiforme
    不详
    DRUG NEWS & PERSPECTIVES, 2005, 18 (05) : 344 - 344
  • [28] Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
    Reardon, David A.
    Lassman, Andrew B.
    van den Bent, Martin
    Kumthekar, Priya
    Merrell, Ryan
    Scott, Andrew M.
    Fichtel, Lisa
    Sulman, Erik P.
    Gomez, Erica
    Fischer, JuDee
    Lee, Ho-Jin
    Munasinghe, Wijith
    Xiong, Hao
    Mandich, Helen
    Roberts-Rapp, Lisa
    Ansell, Peter
    Holen, Kyle D.
    Gan, Hui K.
    NEURO-ONCOLOGY, 2017, 19 (07) : 965 - 975
  • [29] Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme
    Barrié, M
    Couprie, C
    Dufour, H
    Figarella-Branger, D
    Muracciole, X
    Hoang-Xuan, K
    Braguer, D
    Martin, PM
    Peragut, JC
    Grisoli, F
    Chinot, O
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1177 - 1184
  • [30] Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
    Weller, Johannes
    Tzaridis, Theophilos
    Mack, Frederic
    Steinbach, Joachim Peter
    Schlegel, Uwe
    Hau, Peter
    Krex, Dietmar
    Grauer, Oliver
    Goldbrunner, Roland
    Baehr, Oliver
    Uhl, Martin
    Seidel, Clemens
    Tabatabai, Ghazaleh
    Brehmer, Stefanie
    Bullinger, Lars
    Galldiks, Norbert
    Schaub, Christina
    Kebir, Sied
    Stummer, Walter
    Simon, Matthias
    Fimmers, Rolf
    Coch, Christoph
    Glas, Martin
    Herrlinger, Ulrich
    Schaefer, Niklas
    LANCET ONCOLOGY, 2019, 20 (10): : 1444 - 1453
12345